Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells
| Publication | Article in Oncotarget, published August 2017 |
|---|---|
| Authors | Sonja Thaler, Marcus Schmidt, Sven Roßwag, Gitta Thiede, Arno Schad, Jonathan P. Sleeman |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…